Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Masao Omata; Ann Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang Hyub Han; Yoghesh K. Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei Jer Chen; Cosmas Rinaldi A. Lesmana; Laurentius A. Lesmana; Rino A. Gani; Shuntaro Obi; A. Kadir Dokmeci; Shiv Kumar Sarin

doi:10.1007/s12072-017-9799-9

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Masao Omata
, Ann Lii Cheng
, Norihiro Kokudo
, Masatoshi Kudo
, Jeong Min Lee
, Jidong Jia
, Ryosuke Tateishi
, Kwang Hyub Han
, Yoghesh K. Chawla
, Shuichiro Shiina
, Wasim Jafri
, Diana Alcantara Payawal
, Takamasa Ohki
, Sadahisa Ogasawara
, Pei Jer Chen
, Cosmas Rinaldi A. Lesmana
, Laurentius A. Lesmana
, Rino A. Gani
, Shuntaro Obi
, A. Kadir Dokmeci

Shiv Kumar Sarin

Department of Medicine, Medical College, Pakistan

Research output: Contribution to journal › Editorial

1953 Citations (Scopus)

Abstract

There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one of the leading public health problems. Since the “Toward Revision of the Asian Pacific Association for the Study of the Liver (APASL) HCC Guidelines” meeting held at the 25th annual conference of the APASL in Tokyo, the newest guidelines for the treatment of HCC published by the APASL has been discussed. This latest guidelines recommend evidence-based management of HCC and are considered suitable for universal use in the Asia–Pacific region, which has a diversity of medical environments.

Original language	English (US)
Pages (from-to)	317-370
Number of pages	54
Journal	Hepatology International
Volume	11
Issue number	4
DOIs	https://doi.org/10.1007/s12072-017-9799-9
Publication status	Published - 1 Jul 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

APASL
Asia–Pacific
Hepatocellular carcinoma
Treatment algorithm

Access to Document

10.1007/s12072-017-9799-9

Cite this

Omata, M., Cheng, A. L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K. H., Chawla, Y. K., Shiina, S., Jafri, W., Payawal, D. A., Ohki, T., Ogasawara, S., Chen, P. J., Lesmana, C. R. A., Lesmana, L. A., Gani, R. A., Obi, S., ... Sarin, S. K. (2017). Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatology International, 11(4), 317-370. https://doi.org/10.1007/s12072-017-9799-9

@article{a0c108915b5a49eb94063a4bbc6af56d,

title = "Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update",

abstract = "There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one of the leading public health problems. Since the “Toward Revision of the Asian Pacific Association for the Study of the Liver (APASL) HCC Guidelines” meeting held at the 25th annual conference of the APASL in Tokyo, the newest guidelines for the treatment of HCC published by the APASL has been discussed. This latest guidelines recommend evidence-based management of HCC and are considered suitable for universal use in the Asia–Pacific region, which has a diversity of medical environments.",

keywords = "APASL, Asia–Pacific, Hepatocellular carcinoma, Treatment algorithm",

author = "Masao Omata and Cheng, \{Ann Lii\} and Norihiro Kokudo and Masatoshi Kudo and Lee, \{Jeong Min\} and Jidong Jia and Ryosuke Tateishi and Han, \{Kwang Hyub\} and Chawla, \{Yoghesh K.\} and Shuichiro Shiina and Wasim Jafri and Payawal, \{Diana Alcantara\} and Takamasa Ohki and Sadahisa Ogasawara and Chen, \{Pei Jer\} and Lesmana, \{Cosmas Rinaldi A.\} and Lesmana, \{Laurentius A.\} and Gani, \{Rino A.\} and Shuntaro Obi and Dokmeci, \{A. Kadir\} and Sarin, \{Shiv Kumar\}",

note = "Publisher Copyright: {\textcopyright} 2017, The Author(s).",

year = "2017",

month = jul,

day = "1",

doi = "10.1007/s12072-017-9799-9",

language = "English (US)",

volume = "11",

pages = "317--370",

journal = "Hepatology International",

issn = "1936-0533",

publisher = "Springer",

number = "4",

}

Omata, M, Cheng, AL, Kokudo, N, Kudo, M, Lee, JM, Jia, J, Tateishi, R, Han, KH, Chawla, YK, Shiina, S, Jafri, W, Payawal, DA, Ohki, T, Ogasawara, S, Chen, PJ, Lesmana, CRA, Lesmana, LA, Gani, RA, Obi, S, Dokmeci, AK & Sarin, SK 2017, 'Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update', Hepatology International, vol. 11, no. 4, pp. 317-370. https://doi.org/10.1007/s12072-017-9799-9

TY - JOUR

T1 - Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma

T2 - a 2017 update

AU - Omata, Masao

AU - Cheng, Ann Lii

AU - Kokudo, Norihiro

AU - Kudo, Masatoshi

AU - Lee, Jeong Min

AU - Jia, Jidong

AU - Tateishi, Ryosuke

AU - Han, Kwang Hyub

AU - Chawla, Yoghesh K.

AU - Shiina, Shuichiro

AU - Jafri, Wasim

AU - Payawal, Diana Alcantara

AU - Ohki, Takamasa

AU - Ogasawara, Sadahisa

AU - Chen, Pei Jer

AU - Lesmana, Cosmas Rinaldi A.

AU - Lesmana, Laurentius A.

AU - Gani, Rino A.

AU - Obi, Shuntaro

AU - Dokmeci, A. Kadir

AU - Sarin, Shiv Kumar

PY - 2017/7/1

Y1 - 2017/7/1

N2 - There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one of the leading public health problems. Since the “Toward Revision of the Asian Pacific Association for the Study of the Liver (APASL) HCC Guidelines” meeting held at the 25th annual conference of the APASL in Tokyo, the newest guidelines for the treatment of HCC published by the APASL has been discussed. This latest guidelines recommend evidence-based management of HCC and are considered suitable for universal use in the Asia–Pacific region, which has a diversity of medical environments.

AB - There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one of the leading public health problems. Since the “Toward Revision of the Asian Pacific Association for the Study of the Liver (APASL) HCC Guidelines” meeting held at the 25th annual conference of the APASL in Tokyo, the newest guidelines for the treatment of HCC published by the APASL has been discussed. This latest guidelines recommend evidence-based management of HCC and are considered suitable for universal use in the Asia–Pacific region, which has a diversity of medical environments.

KW - APASL

KW - Asia–Pacific

KW - Hepatocellular carcinoma

KW - Treatment algorithm

UR - https://www.scopus.com/pages/publications/85020518973

U2 - 10.1007/s12072-017-9799-9

DO - 10.1007/s12072-017-9799-9

M3 - Editorial

C2 - 28620797

AN - SCOPUS:85020518973

SN - 1936-0533

VL - 11

SP - 317

EP - 370

JO - Hepatology International

JF - Hepatology International

IS - 4

ER -

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this